Mutation analysis of the genes linked to early onset Alzheimer's disease and frontotemporal lobar degeneration

Luukkainen, Laura; Helisalmi, Seppo; Kytövuori, Laura; Ahmasalo, Riitta; Solje, Eino; Haapasalo, Annakaisa; Hiltunen, Mikko; Remes, Anne M.; Krüger, Johanna
 
Avaa tiedosto
Lataukset: 

URL:
https://doi.org/10.3233/JAD-181256

Luukkainen, Laura
Helisalmi, Seppo
Kytövuori, Laura
Ahmasalo, Riitta
Solje, Eino
Haapasalo, Annakaisa
Hiltunen, Mikko
Remes, Anne M.
Krüger, Johanna
IOS Press

Laura Luukkainen, Seppo Helisalmi, Laura Kytövuori, Riitta Ahmasalo, Eino Solje, Annakaisa Haapasalo, … Johanna Krüger. (2019). Mutation Analysis of the Genes Linked to Early Onset Alzheimer’s Disease and Frontotemporal Lobar Degeneration. Journal of Alzheimer’s Disease, 69(3), 775–782. https://doi.org/10.3233/JAD-181256

https://rightsstatements.org/vocab/InC/1.0/
© 2017 IOS Press. The Version of Record can be found at: https://doi.org/10.3233/JAD-181256.
https://rightsstatements.org/vocab/InC/1.0/
doi:https://doi.org/10.3233/JAD-181256
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe2019092329299
Tiivistelmä

Abstract

A lot of effort has been done to unravel the genetics underlying early-onset Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD). However, many familial early-onset dementia (EOD) cases still show an unclear genetic background. The aim of this study was to evaluate the role of the known causative mutations and possible pathogenic variants associated with AD and FTLD in a Finnish EOD cohort. The cohort consisted of 39 patients (mean age at onset 54.8 years, range 39–65) with a positive family history of dementia or an atypical or rapidly progressive course of the disease. None of the patients carried the C9orf72 hexanucleotide repeat expansion. Mutations and variants in APP, PSEN1, PSEN2, MAPT, GRN, VCP, CHMP2B, FUS, TARDBP, TREM2, TMEM106B, UBQLN2, SOD1, PRNP, UBQLN1, and BIN1 were screened by using a targeted next generation sequencing panel. Two previously reported pathogenic mutations (PSEN1 p.His163Arg and MAPT p.Arg406Trp) were identified in the cohort. Both patients had familial dementia with an atypical early onset phenotype. In addition, a heterozygous p.Arg71Trp mutation in PSEN2 with an uncertain pathogenic nature was identified in a patient with neuropathologically confirmed AD. In conclusion, targeted investigation of the known dementia-linked genes is worthwhile in patients with onset age under 55 and a positive family history, as well as in patients with atypical features.

Kokoelmat